Bowel cancer is being missed in young NZers

Publicly released:
New Zealand
Photo by Sasun Bughdaryan on Unsplash
Photo by Sasun Bughdaryan on Unsplash

The number of young people getting bowel cancer is on the rise, but many in NZ are being misdiagnosed, leading to them eventually being diagnosed with more advanced disease. Researchers surveyed 350 people with early-onset bowel cancer, finding that half of them had to wait more than six months for a diagnosis, and a fifth of them had to wait more than a year. Fertility or sexual side-effect counselling was uncommon, and only 13% of respondents said they were given information tailored to younger adults.

News release

From: New Zealand Medical Journal (NZMJ)

Bowel cancer is increasingly being diagnosed in people under 50 years of age, but little is known about patients’ experiences in New Zealand. We surveyed 353 New Zealanders diagnosed with bowel cancer before age 50 and found that many people experienced long delays before receiving a diagnosis, with half waiting 6 months or more from first symptoms to diagnosis and one in five waiting more than a year. Many people were diagnosed with advanced-stage disease and reported that their symptoms were initially attributed to other conditions. Respondents also described gaps in support, including limited information tailored to younger adults, low rates of fertility and sexual health counselling, and challenges related to work, finances and family life. These findings highlight the unique challenges faced by younger people with bowel cancer and the necessity to better understand and support their needs.

Journal/
conference:
NZMJ
Organisation/s: University of Otago, Bowel Cancer New Zealand
Funder: The study survey was co-ordinated by Bowel Cancer New Zealand (BCNZ) in collaboration with the Department of Surgery and Critical Care, University of Otago, Christchurch. Bowel Cancer New Zealand is a nationwide, patient-focussed charity dedicated to beating bowel cancer through life-saving awareness, education, advocacy, research and support. Co-author Frank Frizelle is the Editor in Chief of the New Zealand Medical Journal, a medical advisor for Bowel Cancer NZ, the deputy chair for the bowel cancer registry ANZ and the president of CSSANZ.
Media Contact/s
Contact details are only visible to registered journalists.